{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:08:16Z","timestamp":1792782496519,"version":"4.5.0"},"reference-count":52,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":281,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Intramural Research Programs of the National Institute of Diabetes, Digestive and Kidney Diseases","id":[{"id":"https:\/\/ror.org\/00adh9b73","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health Center for Regenerative Medicine"},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Extramural Program of the National Institutes of Health","award":["NS034007"],"award-info":[{"award-number":["NS034007"]}]},{"name":"Extramural Program of the National Institutes of Health","award":["NS047384"],"award-info":[{"award-number":["NS047384"]}]},{"name":"New York State Department of People with Developmental Disabilities"},{"name":"Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health","award":["R01HD059967"],"award-info":[{"award-number":["R01HD059967"]}],"id":[{"id":"https:\/\/ror.org\/04byxyr05","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Mutation"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1002\/humu.22699","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T05:19:24Z","timestamp":1410844764000},"page":"1485-1494","source":"Crossref","is-referenced-by-count":54,"title":["Identification of Fragile X Syndrome Specific Molecular Markers in Human Fibroblasts: A Useful Model to Test the Efficacy of Therapeutic Drugs"],"prefix":"10.1155","volume":"35","author":[{"given":"Daman","family":"Kumari","sequence":"first","affiliation":[{"name":"Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases; National Institutes of Health; Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Center for Neural Science; New York University; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Nadel","sequence":"additional","affiliation":[{"name":"Section on Neuroadaptation and Protein Metabolism, National Institute of Mental Health; National Institutes of Health; Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Moulton","sequence":"additional","affiliation":[{"name":"Section on Neuroadaptation and Protein Metabolism, National Institute of Mental Health; National Institutes of Health; Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Zeak","sequence":"additional","affiliation":[{"name":"Center for Neural Science; New York University; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Glicksman","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; New York State Institute for Basic Research in Developmental Disabilities; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Dobkin","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; New York State Institute for Basic Research in Developmental Disabilities; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Brick","sequence":"additional","affiliation":[{"name":"National Human Neural Stem Cell Resource; Children's Hospital of Orange County Research Institute; Orange California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip H.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"National Human Neural Stem Cell Resource; Children's Hospital of Orange County Research Institute; Orange California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn B.","family":"Smith","sequence":"additional","affiliation":[{"name":"Section on Neuroadaptation and Protein Metabolism, National Institute of Mental Health; National Institutes of Health; Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Klann","sequence":"additional","affiliation":[{"name":"Center for Neural Science; New York University; New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Usdin","sequence":"additional","affiliation":[{"name":"Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases; National Institutes of Health; Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,11,24]]},"reference":[{"key":"10.1002\/humu.22699-BIB0001|humu22699-cit-0001","first-page":"23","article-title":"Fmr1 knockout mice: a model to study fragile X mental retardation","volume":"78","year":"1994","journal-title":"Cell"},{"key":"10.1002\/humu.22699-BIB0002|humu22699-cit-0002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2008.10.004","article-title":"Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function","volume":"60","author":"Bassell","year":"2008","journal-title":"Neuron"},{"key":"10.1002\/humu.22699-BIB0003|humu22699-cit-0003","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2012.07.022","article-title":"Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice","volume":"76","author":"Bhattacharya","year":"2012","journal-title":"Neuron"},{"issue":"5","key":"10.1002\/humu.22699-BIB0004|humu22699-cit-0004","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nm.3127","article-title":"Targeting the endocannabinoid system in the treatment of fragile X syndrome","volume":"19","author":"Busquets-Garcia","year":"2013","journal-title":"Nat Med"},{"issue":"5","key":"10.1002\/humu.22699-BIB0005|humu22699-cit-0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2353\/jmoldx.2010.090227","article-title":"An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis","volume":"12","author":"Chen","year":"2010","journal-title":"J Mol Diagn"},{"issue":"4","key":"10.1002\/humu.22699-BIB0006|humu22699-cit-0006","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/342931","article-title":"Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome","volume":"71","author":"Coffee","year":"2002","journal-title":"Am J Human Genet"},{"issue":"6174","key":"10.1002\/humu.22699-BIB0007|humu22699-cit-0007","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1126\/science.1245831","article-title":"Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome","volume":"343","author":"Colak","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1002\/humu.22699-BIB0008|humu22699-cit-0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2008.10.055","article-title":"Translational control of long-lasting synaptic plasticity and memory","volume":"61","author":"Costa-Mattioli","year":"2009","journal-title":"Neuron"},{"issue":"11","key":"10.1002\/humu.22699-BIB0009|humu22699-cit-0009","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/nn.3379","article-title":"The translation of translational control by FMRP: therapeutic targets for FXS","volume":"16","author":"Darnell","year":"2013","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1002\/humu.22699-BIB0010|humu22699-cit-0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1002\/humu.22699-BIB0011|humu22699-cit-0011","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mcn.2009.09.013","article-title":"Fragile X mental retardation protein control of neuronal mRNA metabolism: insights into mRNA stability","volume":"43","author":"Rubeis","year":"2010","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"10.1002\/humu.22699-BIB0012|humu22699-cit-0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng0893-335","article-title":"The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation","volume":"4","author":"Devys","year":"1993","journal-title":"Nat Genet"},{"issue":"2","key":"10.1002\/humu.22699-BIB0013|humu22699-cit-0013","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1096-8628(19960809)64:2<296::AID-AJMG13>3.0.CO;2-A","article-title":"Tissue differences in fragile X mosaics: mosaicism in blood cells may differ greatly from skin","volume":"64","author":"Dobkin","year":"1996","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1002\/humu.22699-BIB0014|humu22699-cit-0014","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1113\/jphysiol.2008.150722","article-title":"Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome","volume":"586","author":"Dolen","year":"2008","journal-title":"J Physiol"},{"issue":"5","key":"10.1002\/humu.22699-BIB0015|humu22699-cit-0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.stem.2007.09.001","article-title":"Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos","volume":"1","author":"Eiges","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1002\/humu.22699-BIB0016|humu22699-cit-0016","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopsych.2013.08.003","article-title":"Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice","volume":"75","author":"Franklin","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"9","key":"10.1002\/humu.22699-BIB0017|humu22699-cit-0017","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-8749.1992.tb11521.x","article-title":"The fragile X syndrome","volume":"34","author":"Goldson","year":"1992","journal-title":"Dev Med Child Neurol"},{"key":"10.1002\/humu.22699-BIB0018|humu22699-cit-0018","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2119\/molmed.2011.00363","article-title":"Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110beta-selective inhibitor","volume":"18","author":"Gross","year":"2012","journal-title":"Mol Med"},{"issue":"32","key":"10.1002\/humu.22699-BIB0019|humu22699-cit-0019","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1523\/JNEUROSCI.0402-10.2010","article-title":"Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome","volume":"30","author":"Gross","year":"2010","journal-title":"J Neurosci"},{"issue":"152","key":"10.1002\/humu.22699-BIB0020|humu22699-cit-0020","doi-asserted-by":"crossref","first-page":"152ra128","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen","volume":"4","author":"Henderson","year":"2012","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1002\/humu.22699-BIB0021|humu22699-cit-0021","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/hmg\/4.3.359","article-title":"Tissue-specific expression of a FMR1\/beta-galactosidase fusion gene in transgenic mice","volume":"4","author":"Hergersberg","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1002\/humu.22699-BIB0022|humu22699-cit-0022","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ng0193-36","article-title":"Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome","volume":"3","author":"Hinds","year":"1993","journal-title":"Nat Genet"},{"issue":"3","key":"10.1002\/humu.22699-BIB0023|humu22699-cit-0023","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1601-183X.2012.00768.x","article-title":"Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome","volume":"11","author":"Hoeffer","year":"2012","journal-title":"Genes Brain Behav"},{"issue":"7","key":"10.1002\/humu.22699-BIB0024|humu22699-cit-0024","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ajmg.a.36511","article-title":"Epidemiology of fragile X syndrome: a systematic review and meta-analysis","volume":"164","author":"Hunter","year":"2014","journal-title":"Am J Med Genet"},{"issue":"10","key":"10.1002\/humu.22699-BIB0025|humu22699-cit-0025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/cercor\/10.10.1038","article-title":"Dendritic spine structural anomalies in fragile-X mental retardation syndrome","volume":"10","author":"Irwin","year":"2000","journal-title":"Cereb Cortex"},{"issue":"14","key":"10.1002\/humu.22699-BIB0026|humu22699-cit-0026","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/hmg\/10.14.1449","article-title":"Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers","volume":"10","author":"Kenneson","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1002\/humu.22699-BIB0027|humu22699-cit-0027","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jmoldx.2013.02.006","article-title":"Fragile X screening by quantification of FMRP in dried blood spots by a Luminex immunoassay","volume":"15","author":"LaFauci","year":"2013","journal-title":"J Mol Diagn"},{"issue":"3","key":"10.1002\/humu.22699-BIB0028|humu22699-cit-0028","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.nbd.2011.12.037","article-title":"Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome","volume":"45","author":"Liu","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1002\/humu.22699-BIB0029|humu22699-cit-0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/humu.22177","article-title":"Somatic expansion in mouse and human carriers of fragile X premutation alleles","volume":"34","author":"Lokanga","year":"2013","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1002\/humu.22699-BIB0030|humu22699-cit-0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.nbd.2010.10.018","article-title":"BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse","volume":"41","author":"Louhivuori","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1002\/humu.22699-BIB0031|humu22699-cit-0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110892","article-title":"Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks","volume":"441","author":"Magnuson","year":"2012","journal-title":"Biochem J"},{"issue":"5","key":"10.1002\/humu.22699-BIB0032|humu22699-cit-0032","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuron.2005.01.038","article-title":"Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome","volume":"45","author":"McBride","year":"2005","journal-title":"Neuron"},{"issue":"1","key":"10.1002\/humu.22699-BIB0033|humu22699-cit-0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","article-title":"Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice","volume":"74","author":"Michalon","year":"2012","journal-title":"Neuron"},{"issue":"3","key":"10.1002\/humu.22699-BIB0034|humu22699-cit-0034","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acid Res"},{"issue":"20","key":"10.1002\/humu.22699-BIB0035|humu22699-cit-0035","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1523\/JNEUROSCI.0937-07.2007","article-title":"Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome","volume":"27","author":"Muddashetty","year":"2007","journal-title":"J Neurosci"},{"issue":"1","key":"10.1002\/humu.22699-BIB0036|humu22699-cit-0036","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.a.32087","article-title":"Fragile X full mutation alleles composed of few alleles: implications for CGG repeat expansion","volume":"146A","author":"Nolin","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1002\/humu.22699-BIB0037|humu22699-cit-0037","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuron.2012.01.034","article-title":"Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome","volume":"77","author":"Osterweil","year":"2013","journal-title":"Neuron"},{"issue":"46","key":"10.1002\/humu.22699-BIB0038|humu22699-cit-0038","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1523\/JNEUROSCI.3888-10.2010","article-title":"Hypersensitivity to mGluR5 and ERK1\/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome","volume":"30","author":"Osterweil","year":"2010","journal-title":"J Neurosci"},{"issue":"2","key":"10.1002\/humu.22699-BIB0039|humu22699-cit-0039","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BJ20101024","article-title":"Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)","volume":"431","author":"Pearce","year":"2010","journal-title":"Biochem J"},{"issue":"6","key":"10.1002\/humu.22699-BIB0040|humu22699-cit-0040","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s11064-007-9545-0","article-title":"Age- and sex-dependent differential interaction of nuclear trans-acting factors with Fmr-1 promoter in mice brain","volume":"33","author":"Prasad","year":"2008","journal-title":"Neurochem Res"},{"issue":"20","key":"10.1002\/humu.22699-BIB0041|humu22699-cit-0041","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1523\/JNEUROSCI.0093-05.2005","article-title":"Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse","volume":"25","author":"Qin","year":"2005","journal-title":"J Neurosci"},{"issue":"4","key":"10.1002\/humu.22699-BIB0042|humu22699-cit-0042","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/jcbfm.2012.205","article-title":"Altered cerebral protein synthesis in fragile X syndrome: studies in human subjects and knockout mice","volume":"33","author":"Qin","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1002\/humu.22699-BIB0043|humu22699-cit-0043","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-pathol-011811-132457","article-title":"Molecular mechanisms of fragile X syndrome: a twenty-year perspective","volume":"7","author":"Santoro","year":"2012","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1002\/humu.22699-BIB0044|humu22699-cit-0044","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","article-title":"Dysregulation of mTOR signaling in fragile X syndrome","volume":"30","author":"Sharma","year":"2010","journal-title":"J Neurosci"},{"issue":"10","key":"10.1002\/humu.22699-BIB0045|humu22699-cit-0045","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/jnr.23245","article-title":"Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling","volume":"91","author":"Stover","year":"2013","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1002\/humu.22699-BIB0046|humu22699-cit-0046","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/1.6.397","article-title":"DNA methylation represses FMR-1 transcription in fragile X syndrome","volume":"1","author":"Sutcliffe","year":"1992","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1002\/humu.22699-BIB0047|humu22699-cit-0047","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1002\/humu.22699-BIB0048|humu22699-cit-0048","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.3353","article-title":"Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology","volume":"19","author":"Udagawa","year":"2013","journal-title":"Nat Med."},{"issue":"3","key":"10.1002\/humu.22699-BIB0049|humu22699-cit-0049","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nurt.2010.05.005","article-title":"Fragile X: leading the way for targeted treatments in autism","volume":"7","author":"Wang","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1002\/humu.22699-BIB0050|humu22699-cit-0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1471-4159.2012.07722.x","article-title":"Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome","volume":"121","author":"Wang","year":"2012","journal-title":"J Neurochem"},{"issue":"10","key":"10.1002\/humu.22699-BIB0051|humu22699-cit-0051","doi-asserted-by":"crossref","first-page":"e26549","DOI":"10.1371\/journal.pone.0026549","article-title":"Reversal of fragile X phenotypes by manipulation of AbetaPP\/Abeta levels in Fmr1KO mice","volume":"6","author":"Westmark","year":"2011","journal-title":"PloS One"},{"issue":"2","key":"10.1002\/humu.22699-BIB0052|humu22699-cit-0052","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jmg.35.2.103","article-title":"Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats","volume":"35","author":"Wohrle","year":"1998","journal-title":"J Med Genet"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.22699","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.22699","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.22699\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:55:03Z","timestamp":1672314903000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.22699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,24]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.22699","archive":["Portico"],"relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,24]]}}}